Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CuraGen (CRGN) -- Ignore unavailable to you. Want to Upgrade?

To: mike head who wrote (107)	9/8/1999 1:08:00 PM
From: Jim Oravetz	Respond to of 478

NEW HAVEN, Conn. (Dow Jones)--CuraGen Corp. (CRGN) received $15 million through a private placement of 1.5 million newly issued CuraGen common shares to funds managed by Pequot Capital Management Inc. In a press release Wednesday, CuraGen said it plans to invest the proceeds in the continued refinement and expansion of its base of functional genomics technologies and databases. These technologies are driving near-term revenues by advancing the product discovery and development efforts of the company's collaborators. CuraGen develops pharmaceutical and life science products through the application of genomics. Jim